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Background: We investigated the potential of galangal rhizomes to induce cytotoxic and apoptotic effects in the
cultured human breast carcinoma cell line, (MCF-7) in compare with the non-malignant (MRC-5) cells.
Methods: Both cells were cultured in DMEM medium and treated with galangal rhizomes for three consecutive days.
The percentage of apoptotic cells was determined by flow cytometry using Annexin-V fluorescein isothiocyanate.
Results: The results showed that the ethanolic extract of galangal rhizomes decreased cell viability in the malignant
cells as a concentration- and time- dependent manner. The IC50 values against MCF-7 were determined at 400.0 ± 11.7
and 170.0 ± 5.9 μg/ml after 48 and 72 h respectively. The morphology of MCF-7 cells treated with the ethanolic extract
confirmed the cell proliferation assay results. Alpinia galanga induced apoptosis in MCF-7 cells, as determined by flow
cytometry.
Conclusions: We concluded that the extract of Alpinia galanga exerts pro-apoptotic effects in a breast cancer-derived
cell line and could be considered as a potential chemotherapeutic agent in breast cancer.
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Breast cancer is the second leading cause of cancer
deaths among woman. Unfortunately, the development
of resistance to chemotherapeutic agents is a common
obstacle in the treatment of different types of cancers in-
cluding breast cancer [1]. Several important drugs with
different structures and mechanisms of anti-tumor activ-
ities fail to be effective due to the drug resistance [2]
and also the failure of the conventional chemotherapy to
affect a major reduction in mortality indicates that the
new approaches are critically needed [3]. It has been rec-
ognized that a large groups of therapeutic agents can
stop cancer cells proliferation by inducing apoptosis.
The induction of apoptosis has been emphasized in an-
ticancer strategies [4]. Apoptosis is a gene regulated
phenomenon which is induced by many chemothera-
peutic agents in cancer treatment [5]. It is characterized* Correspondence: samarghandians@mums.ac.ir
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distribution, and reproduction in any mediumby a series of typical morphological features, such as nu-
clear and cellular convolution, chromatin condensation
and the final disintegration of the cell into membrane-
bound apoptotic bodies which are phagocytosed by neigh-
boring cells [6]. Most normal cells can die by apoptosis
but tumor cells very often have some defects in the apop-
totic pathway, leading not only to the increase of tumor
mass but also to tumor resistance to chemotherapy. Since
chemotherapy and irradiation act primarily by inducing
apoptosis, defects in the apoptotic pathway make the ther-
apy less efficient [7]. Increasing evidences suggest that the
related processes of neoplastic transformation involve al-
teration of the normal apoptotic pathway [8]. The major
focus of the research in chemotherapy for cancer in recent
times is the use of naturally occurring compounds with
the chemopreventive and chemotherapeutic properties
in the treatment of cancers [9,10]. Epidemiological
studies suggest that a diet rich in antioxidants may help
to prevent the development of breast carcinoma [11].
Excess generation of oxygen free radicals can cause oxida-
tive damage to bimolecular resulting in lipid peroxidation,Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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oxidative stress, and thus oxidation and free radicals may
be important in carcinogenesis at multiple tumor sites
[12]. The antioxidant activity may be the result of the spe-
cific scavenging of reactive free radicals, scavenging of
oxygen containing compounds such as hydrogen peroxide
and chelating metals [13,14]. Phytochemical and dietary
antioxidants may decrease the risk of much chronic dis-
ease such as cancer. Antioxidants scavenge free radicals,
and consequently are a very special group of nutrition
supplements [15]. Plants have played an important role as
a source of effective anticancer agents, and it is significant
that 60% of currently used anticancer agents are derived
from natural sources including plants, marine organisms,
and microorganisms [16]. Alpina galanga (galangal) is a
well-known plant in the Southeast Asia. The rhizomes of
Zingiberaceae family are widely used in many ancient
countries in traditional medicine which is found to be ef-
fective in the treatment of diseases [17]. Their function
have been broadly discussed and accepted in many trad-
itional recipes. Alpinia galangal has bben studied by vari-
ous researchers and a number of active constituents from
the plant have been isolated and reported. Phenolic com-
pounds such as flavonoids and phenolic acids are found
abundantly in this plant [18]. The dominant components
isolated from the rhizomes were galangoisoflavonoid
[19], β-sitosterol diglucosyl caprate [20], methyleugenol,
p-coumaryl diacetate, 1′-acetoxyeugenol acetate, trans-p-
acetoxycinnamyl alcohol, trans-3,4-dimethoxycinnamyl al-
cohol, p-hydroxybenzaldehyde, p-hydroxycinnamaldehyde,
trans-p-coumaryl alcohol, galangin, trans-p-coumaric acid,
and galanganol B [21]. The major phytoconstituents which
have been isolated from the rhizomes are acetoxychavicol
acetate (ACA) and hydroxychavicol acetate (HCA) [22].
Rhizomes are lowest in fat but richest in carbohydrate [23].
The chemical investigation of A. galanga has led to the iso-
lation of β-caryophyllene (17.95%) and β-selinene (10.56%),
terpinen-4-ol [24], 4-allylphenyl acetate and β-bisabolene,
5-hydroxymethyl furfural (59.9%), benzyl alcohol (57.6%),
methylcinnamate (9.4%), 3-phenyl-2-butanone (8.5%) and
1,2-benzenedicarboxylic acid (8.9%) [25]. A new phenylpro-
panoid, 4,4′[(2E, 2′E)-bis(prop-2-ene)-1,1′-oxy]-diphenyl-
7,7′-diacetata [26], as well as p-coumaryl alcohol-γ-O-methyl
ether (CAME) and p-coumaryl diacetate (CDA), has
also been isolated from the plant [27,28]. Volatile oil of
plant contained zerumbone (44.9%), β-farnesene, myrcene
and 1,8-cineole, respectively [29,30]. Bicyclo (4.2.0) oct-1-
ene, 7-exoethenyl (58.46%), trans-caryophyllene (7.05%),
α-pinene (14.94%) with camphene (2.15%), germacrene
(1.78%) and citronellyl acetate (1.41%) were reported in
A.galanga as major components [31]. Several authors
have studied the anti-inflammatory and analgesic ef-
fects of A. galanga in a variety of rheumatological con-
ditions [26,27,32,33]. The extracts of A. galanga showedacetylcholinesterase-inhibitory [34], platelet-activating fac-
tor (PAF)-inhibitory [35], antimicrobial [36], antibacterial
[37], anti-amoebic [38], antifungal [39], antioxidant [28]
and apoptosis [40] activities. It has been reported that
Alpinia plants possess antioxidant [41], anti-inflammatory
[42], immunostimulating [43], antinociceptive [44], hepa-
toprotective [45] and anticancer [46] activities. However
our information about anticancer activates of galangal is
very few. To prevent initiation and promotion carcinogen-
esis, administration of nationally accruing agent is being
increasingly appreciated. In this study, the anticancer ef-
fects of the ethanolic extract of galangal on the cultured
human breast carcinoma, MCF-7 cells, was investigated.
Methods
Chemicals and reagents
3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium brom-
ide (MTT) was purchased from Amerso (USA). Dulbecco’s
modified Eagle’s medium (DMEM) was purchased from
Gibco BRL (Grand Island, NY, USA). Annexin V/fluor-
escein isothiocyanate (FITC) was obtained from Invitrogen
Corporation (Camarillo, CA, USA). Fetal bovine serum
was purchased from PAA Laboratories GmbH, Austria.
Preparation of the galangal extract
Protocols of current study were approved by the Ethical
Committee of Mashhad Medical University. The Fresh
rhizomes of alpinia galanga used in this study was col-
lected from a private garden in the flowering period in
india and identified by botanists in the herbarium of
Ferdowsi University of Mashhad and also has been de-
posited in the herbarium. Voucher specimen is depos-
ited in the specially maintained herbarium, Department of
Botany, Ferdowsi University of Mashhad. The cleaned
fresh rhizomes were cut into small pieces and air-dried.
The dried powder (50 g) was mixed with ethanol (97%)
in a balloon; the balloon was shaken for 3 days at room
temperature. The preparation was then filtered off
through a Gauze mesh and the solvent was dried by
evaporation under reduced pressure at 45°C. The final
product yielded 12% w/w dried extract; it was stored in
a refrigerator until the experiment.
Cell culture
The human breast adenocarcinoma cell line (MCF-7)
and the human fetal lung fibroblast cell line (MRC-5)
were obtained from Pasteur Institute (Tehran, Iran). The
cells were grown either in 96-well tissue (TC) plate
(NUNC, Wiesbaden, Germany) or in 25-cm2 TC flasks
(NUNC, Wiesbaden, Germany), cells were cultured in
CO2 incubator MCO-17AI (Sanyo Electric Co., Ltd,
Japan) at 37°C in 95% humidified atmosphere enriched
by 5% CO2 and subcultured every 3 to 4 days. The ma-
lignant (MCF-7) and nonmalignant cells (MRC-5) were
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vine serum (Gibco–Invitrogen), 100 U/ml of penicillin
(Gibco–Invitrogen), and 100 μg/ml streptomycin (Gibco–
Invitrogen).
Cell viability assay
Cell viability was measured using the MTT assay, which
is based on the conversion of MTT to formazan crystals
by mitochondrial dehydrogenises [6]. Briefly, both cell
lines were plated at a density of (1 × 103 cells/ml) in 96-
well plates. Cells were seeded overnight, and then incu-
bated with various concentrations of galangal rhizomes
extract (0, 125, 250, 500, and 750 μg/ml) for 24, 48 h
and 72 h. For MTT assay, after treatment with the galan-
gal extract for 24 and 48 and 72 h, 10 μl MTT was
added into each well. After removing the medium, the
cells were then labeled with MTT solution) 5 mg/ml in
PBS) for 4 h and the resulting Formosan was solubilized
in 100 μl dimethyl sulfoxide (DMSO). Absorbance was
measured at 570 nm using an automated microplate
reader (Bio-Rad 550). The absorption was measured at
570 nm (620 nm as a reference) in an ELISA reader. The
cytotoxic effects of the galangal extract on the cell lines
(MCF-7 and MRC-5) were expressed as the IC50 value
(the drug concentration reducing the absorbance of
treated cells by 50% with respect to untreated cells). All
experiments were carried out in triplicate
Morphological studies of cell lines using the normal
inverted microscope
Morphological studies using the normal inverted micro-
scope were carried out to observe the morphological
changes of cell death in MCF-7 and MRC-5 cell lines
elicited by the ethanolic extract of galangal. Different
concentrations of galangal extract (0, 125, 250, 500, and
750 μg/ml) for 24, 48 h and 72 h were used for the mor-
phological studies. The untreated cells served as the
negative control. The morphological changes of the cells
were observed under the normal inverted microscope
after 24 and 48 h post-treatment.
Annexin V/PI staining and flow cytometry analysis
Apoptotic cell death was measured using a flouresin iso-
thiocynate (FITC)-conjugated Annexin V/PI assay kit by
flow cytometry. Briefly, MCF-7 cells (1 × 106 cells) treated
with the galangal extract at concentrations of 250 and
500 μg/ml for 48 h were harvested and washed twice
with cold PBS (phosphate-buffered saline) resuspended
in 100 μl binding buffer, and stained with 5 μl of FITC-
conjugated Annexin V (10 mg/ml) and 10 μl of propi-
dium iodide (PI) (50 mg/ml). The cells were incubated
for 15 min at room temperature in the dark, 400 μl of
binding buffer was added, and the cells were analyzed
(FACScan, Becton- Dickinson, USA). The MCF-7 cellswere gated separately according to their granularity and
size on forward scatter (FSC) versus Side Scatter (SSC)
plots. The early and late apoptosis were evaluated on
fluorescence 2 (FL2 for PI) versus fluorescence 1 (FL1 for
Annexin) plots. Cells stained with only annexin V were
evaluated as being in the early apoptosis; cells stained with
both annexin V and PI were evaluated as being in the late
apoptosis or in the necrotic stage [7,47].
Statistical analysis
All results were expressed as mean ± SEM. The signifi-
cance of difference was evaluated with ANOVA and




To discriminate between the early and late effects of
galangal rhizomes action, the malignant (MCF7) and
non-malignant control (MRC-5) cells were exposed to
increasing the galangal rhizomes concentrations for 24,
48 and 72 h (Figure 1).
After 48 h of incubation with the ethanolic extract of
galangal rhizomes (250, 500, and 750 μg/ml) morphologic
changes were observed in MCF-7 cells versus MRC-5 cells
which is consisting of reduction in the number of living
cells, volume and rounding until the nucleus constituted
the majority of the cellular volume. No morphological
changes were detected in MRC-5 cells. Our data showed
the reduction of MCF-7 cells compared with MRC-5 cells.
Our MTT result showed that this cytotoxicity was in-
creased at higher concentrations (Figure 1), so that, the
galangal rhizomes treated MCF-7 (125 μg/ml) were dam-
aged but there were no morphological changes in galangal
rhizomes treated MRC-5 cells at the same concentration,
this effect again became obvious at the other concentra-
tion (250 μg/ml). Although the morphological features
were not dramatically changed in the MCF-7 versus
MRC-5 cells after 24 h at lower concentration(data was
not shown), however after 72 h, at concentration (125,
250 μg/ml), there was observationally sever difference be-
tween galangal rhizomes - treated MCF-7 and MRC-5
cells at morphological level (Figure 2).
Effects of galangal on cell viability
In order to evaluate the effect of the ethanolic extract of
galangal rhizomes on the growth of MRC-5 and MCF-7
human breast cancer cells, the cells were treated with
different concentrations of galangal rhizomes for 3 con-
secutive days and their growth inhibitory effects were
compared. The impact of the galangal rhizomes extract
on cell viability was quantitated by the MTT assay. The
ethanolic galangal rhizomes extract showed significantly
a high growth inhibitory effects on MCF-7 cell line in
Figure 1 Effect of galangal extract on morphological evaluation in MCF-7 and MRC-5 cells after 48 h treatment.
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cells. The ethanolic extract (250, 500, 750 μg/ml) decreased
the cell viability in the malignant cells but not in non-
malignant cells after 24 h (p < 0.01) (Figure 3A). This toxicity
was consistent with the morphologic changes. However, the
extract at the different concentrations (125 μg/ml) could not
decrease the cell viability in compare with the MRC-5 cells.
After 48 h, the higher concentrations of ethanolic extract
(500, 750 μg/ml) dramatically decreased the cell viability in
the MCF-7 cells (p < 0.001) (Figure 3B). After 72 h, again
the ethanolic extract statistically deceased cell viability in
MCF-7 cells versus MRC-5 cells even at the lower concen-
tration (125 μg/ml) (Figure 3C). The dose inducing 50%
cell growth inhibition (IC50) against MCF-7 cells was de-
termined as 400.0 ± 11.7 and 170.0 ± 5.9 μg/ml after 28
and 48 h respectively (Table 1).
Induction of apoptosis in MCF-7 cells by galangal
In order to assess the rate of cell death by apoptosis or
necrosis, the galangal-treated MCF-7 cells were assayed
by Annexin V-FITC/PI dual staining (Figure 4). As it
can be seen in Figure 4, the malignant cells were treated
with concentrations of 250 and 500 μg/ml galangal for
48 h, then the cells were harvested, and apoptosis was
examined by flow cytometry. The cells were treated withFigure 2 Effect of galangal extract on morphological evaluation
in MCF-7 and MRC-5 cells after 72 h treatment.250 and 500 μg/ml galangal for 48 h(symbol П, ПΙ) or
media (control symbol Ι), and apoptosis was examined
with flow-cytometry after Annexin V-PI double staining.
The necrotic cells lost cell membrane integrity that per-
mits PI entry. The viable cells exhibit Annexin V (−)/PI
(−); early apoptotic cells exhibit Annexin (+)/ PI (−); late
apoptotic cells or necrotic cells exhibit Annexin V (+)/PI
(+). To study roles of galangal in apoptosis, the ethanolic
extract of galangal was used to setup apoptosis system
on the MCF-7 cells. Quantitative analysis using annexin
V/PI assay further showed that the proportion of the
early-stage apoptotic cells (annexin V+/PI−) increased
significantly from 9.5% to 31.5%, while proportion of the
late stage apoptotic cell (annexin V+/PI+) increased sig-
nificantly from 13.5% to 39.5% in the cells were treated
with 250 and 500 μg/ml galangal extract for 48 h re-
spectively. Apoptosis induced by 250 and 500 μg/ml of
galangal was statistically higher than control, and the
percentage of early and late apoptotic cells signifi-
cantly increased by increasing the galangal concentra-
tions (p < 0.05). At 48 h, the total early apoptotic cells
were significantly elevated from 2% (control) to 9.5
and 31.5%.at 250 and 500 μg/ml respectively. The percent-
age of the late apoptotic/necrotic cells increased from 6%
(control) to 13.5 and 39.5% at 250 and 500 μg/ml respect-
ively (Figure 5). Although no significant difference was de-
tected between the percentage of early and late apoptotic
cells at concentration of 250 μg/ml, however, the number
of late apoptotic cells versus to early apoptotic cells at
concentration of 500 μg/ml galangal treated cells was stat-
ically significant (p < 0.001); thus, the percentage of late
apoptotic cells increased significantly versus the percent-
age of early apoptotic cells.
Discussion
Several studies have shown that a number of herbal medi-
cine or mixtures have anticancer potential in vitro and
in vivo. They might be good candidate for the develop-
ment of anti-cancer drugs [48]. Most chemo-preventive
agents suppress the various stages of signaling events of
Figure 3 Comparison cytotoxic effect of galangal extract on cell viability of MCF-7 and MRC-5 cells. Cells were treated with different
concentrations of the extract for 24 h (A), 48 h (B) and 72 h (C), results are mean ± SEM(n = 6). *p < 0.05, **p < 0.01 and ***p < 0.001 compared to
control (MRC-5).
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striking inhibition of diverse cellular events related to can-
cer development. Inhibition of cancer cell proliferation,
growth factor signaling, induction of apoptosis in cells with
malignant potential, etc., contributes for chemo-preventive
properties. Increasing evidences suggest that most chemo-
preventive agents are capable of inducing apoptosis in the
target cancer cells either with mitochondrial or by an
uncharacterized mechanism in certain cases [49,50]. Search
for novel agents from plants with promising features of
apoptosis induction in cancer cells is an attractive strategy.
Alpinia galangal is known to possess flavanoids such
as kaempferol, kaempferide, and galangin as well as the
terpenoids 10-acetoxy chavicol acetate, 10-acetoxy eu-
genol, galanal A, galanal B, and galanolactone [47]. WeTable 1 Doses induce 50% cell growth inhibition (IC50) of
ethanolic galangal extract against MCF-7 cell line
IC50 48 h 72 h
MCF7 500 (μg/ml) 250 (μg/ml)are reporting for the first time that the ethanolic extract
of galangal rhizome-induced cytotoxicity and apoptosis
on MCF-7 cells versus MRC-5 cells. Much effort has
been directed toward the effect of the galangal extract
on apoptosis and understanding their mechanisms of ac-
tion. To study whether the result of MTT assay was due
to apoptosis, cells were stained with Annexin V-FITC
and PI. The apoptosis evoked by the extract was con-
firmed by the annexin V–FITC (Figure 3). In the present
study, the galangal-induced apoptosis was involved in
cell death. Apoptosis is characterized by distinct mor-
phological features including the chromatic condensa-
tion, cell and nuclear shrinkage, membrane blabbing, and
oligonucleosomal DNA fragmentation [51]. As shown in
Figures 3 and 4, the Alpina extract at 250 and 500 μg/ml
induced significant cell toxicity in MCF-7 cells in a dose-
dependent manner. Therefore, this anti-proliferative effect
was due to the induction of apoptosis as shown by the
annexin-V-flow cytometric approach. But, apoptosis only
partially contributed in this toxicity, and it might be
Figure 4 Assessment of apoptosis by Annexin V/PI staining on the human breast adenocarcinoma cell line (MCF-7). The cells were
treated with 250 and 500 μg/ml galangal extract for 48 h (symbol II, III) or media (control symbol I), and apoptosis was examined with flow-cytometry
after Annexin V-PI double staining. The necrotic cells lost cell membrane integrity that permits PI entry .Viable cells exhibit Annexin V (−)/PI (−); early
apoptotic cells exhibit Annexin (+)/PI (−); late apoptotic cells or necrotic cells exhibit Annexin V (+)/PI (+).
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volved in the galangal-induced toxicity in these cells. Al-
though the significant of nonapoptotic cell death in
chemotherapy remains largely unclear, it is believed that
the nonapoptotic cell death is important under conditions
in which apoptosis is inhibited [52,53]. Overall, this study
showed that the alpina extarct may contain bioactive com-
pounds that inhibit the proliferation of breast cancer cell
lines (MCF-7) with the involvements of apoptosis or pro-
grammed cell death. Further studies are needed to fully
recognize the mechanism involved in cell death, alpina ex-
tract could be considered as promising chemotherapeutic
agent in lung cancer treatment.
The fresh rhizomes of galangal has been assessed
for free radical scavenging activity against 1, 1- diphenyl-
2-picrylhydrazyl (DPPH) radical and cytotoxic activity. It
has been reported that Alpinia plants possess antioxidantFigure 5 Assessment of apoptosis by Annexin V/PI on the
human breast adenocarcinoma cell line (MCF-7) after 48 h.
Percentage of cell death based on the assessment of apoptosis by
Annexin V/PI. ***, ### p < 0.001 compared with control and the
other dose respectively. $ p < 0.05 compared with early apoptosis.[33]. In vitro cell proliferation inhibition test using
MTT viability assay confirmed that the ethanolic extract
at 24, 48 and 72 h, has strongly cytotoxic activity against
MCF-7 cell line but not in nonmalignant cells (MRC-5)
(Figure 3). The present results were consistent with
previous studies indicating that MeOH and CH2Cl2
extractable of Alpinia possess significant cytotoxicity
against CORL23 human large-cell carcinoma with IC50
values of 13.3 and 5.4 μg/ml respectively [48]. xPresent
data were also consistent with previous studies indicat-
ing that galangal rhizomes and its ingredients possess
cytotoxcity and free radical scavenging activities [54,55].
Phytochemical studies showed that of the many chemical
constituents isolated from Alpinia, diaryheptanods, are
among the characteristic compounds [56]. Curcumin, a
well-known diarylheptanoid, has been postulated to be of
potential use not only in cancer chemo-prevention but also
in chemotherapy [57]. Two new diarylheptanoids 1, 2 to-
gether with two known analogs 3, 4 were isolated from the
rhizomes of Alpinia officinarum. The new compounds were
elucidated to be (5S)-5-hydroxy-7-(3, 4-dihydroxyphenyl)-
1-phenyl-3-heptanone 1 and (5R)-5-hydroxy-7-(3-methoxy-
4, 5-dihydroxyphenyl)-1-phenyl-3-heptanone 2 based on
their spectral analysis. Compound 4 showed moderate cyto-
toxicity against human tumor cell lines; HepG2 and SF-268,
while no significant effect were found for compounds 1–3
[58]. Ning and Pan tested compounds 1–4 for their cytotoxic
activity against human cancer cell lines. They showed that
compound 4 even at low concentration (6–10 μg/ml) exhib-
ited potent cytotoxicity against all cell lines [59,60]. Galangal
rhizomes also contains pinocembrin (5, 7-dihdroxyflavanone)
that shows cytotoxicity against some cancer cells including
normal lung fibroblasts with relative nontoxicity to human
umbilical cord endothelial cells. Pinocembrin induced loss
of mitochondrial membrane potential with subsequent
release of cytochrome c and processing of caspase-9
and −3 colon cancer cell line HCT116 [50]. Therefore, it
seems likely that potential compounds responsible for the
inhibitory effect of galangal on tumor cell growth are its
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significantly proliferation of the human breast adenocar-
cinoma cells in a concentration- and time-dependent
manner versus the normal human fetal lung fibroblast.
The morphological features also confirmed these results.
We also showed that apoptosis induced by the galangal
extract was significantly higher than control, and the
percentage of the both early and late apoptotic cells
statistically increased by increasing galangal concentra-
tion. On the other hand, although no significant differ-
ence was detected between the percentage of early and
late apoptotic cells at lower concentration, however,
the number of the late apoptotic cells versus the early
apoptotic cells at higher concentrations of the galangal
treated cells was statically significant.
Generally, apoptosis can occur via two fundamental
pathways: (1) the mitochondrial or intrinsic pathway; and,
(2) the death receptor or extrinsic pathway [61]. The in-
trinsic pathway is triggered by release of mitochondrial
proteins, such as cytochrome c, which bind with Apaf-1
and procaspase-9 in a dATP-dependent manner to form
the apoptosome [62]. The apoptosome can induce acti-
vation of caspase- 9, thereby initiating apoptotic cas-
pase cascades [63,64]. Conversely, the extrinsic pathway
is initiated by the interaction of ligands with their re-
spective death receptors, sequentially leading to cleav-
age of initiator caspase-8. The active caspase-8 cleaves
executioner caspase-3, resulting in apoptosis [65]. Acti-
vated caspase-9 and −8 further initiate activation of the
caspase cascade, leading to biochemical and morpho-
logical changes associated with apoptosis [66,67]. Thus
caspases have been shown to be activated during apop-
tosis in many cells and play critical roles in both initi-
ation and execution of apoptosis [68]. The intrinsic
pathway of apoptosis is regulated by the Bcl-2 family of
proteins. Anti-apoptotic (e.g. Bcl-2 and Bcl-xL) and
pro-apoptotic (e.g. Bad, Bax and Bak) are two of the
major members in Bcl-2 family [69-71]. Anti-apoptotic
Bcl-2 and Bcl-xL inhibit apoptosis by sequestering pro-
forms of capsases or by preventing the release of mito-
chondrial apoptogenic factors [72,73]. Bad, Bax and
Bak inhibit Bcl-2 activity and promote apoptosis [74].
These experimental findings suggest that A.galangal ex-
tract induced MCf-7 cells apoptosis however, further
detailed investigations of this mechanism are warranted
to obtain definite conclusions.
Conclusion
Overall, this study showed that the galangal extract may
contain bioactive compounds that inhibit the proliferation
of the human breast adenocarcinoma cell line (MCF-7)
with the involvement of apoptosis or programmed cell
death. Further research focuses on galangal gradients are
needed to fully recognize the mechanisms involved in celldeath. The ethanolic extract of galangal could be also con-
sidered as a promising chemotherapeutic agent in breast
cancer treatment.
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